Who Really Benefits from 3D-Based Planning of Brachytherapy for Cervical Cancer?
In Bong HaBae Kwon JeongKi Mun KangHojin JeongYun Hee LeeHoon Sik ChoiJong Hak LeeWon Jun ChoiJeong Kyu ShinJin-Ho SongPublished in: Journal of Korean medical science (2018)
These findings indicate that 3D-based ICR plans improve tumor coverage while satisfying the dose constraints for OARs. 3D-based ICR should be considered in patients with tumors > 4 cm size at the time of brachytherapy or > 5 cm initially.